Amy Schacterle
Geschäftsführer bei SAGE THERAPEUTICS, INC.
Aktive Positionen von Amy Schacterle
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SAGE THERAPEUTICS, INC. | Geschäftsführer | 01.04.2020 | - |
| Technik-/Wissenschafts-/F&E-Leiter | 01.04.2020 | - | |
| General Counsel | 13.02.2015 | 01.04.2020 |
Karriereverlauf von Amy Schacterle
Ehemalige bekannte Positionen von Amy Schacterle
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | General Counsel | 01.01.2004 | 01.01.2014 |
Ausbildung von Amy Schacterle
| Rensselaer Polytechnic Institute | Undergraduate Degree |
| University of Virginia | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| General Counsel | 2 |
| Chief Operating Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SAGE THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Health Technology |
- Börse
- Insiders
- Amy Schacterle
- Erfahrung
